focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 31.00
Ask: 34.00
Change: 0.00 (0.00%)
Spread: 3.00 (9.677%)
Open: 32.50
High: 32.50
Low: 32.50
Prev. Close: 32.50
TPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract wins and update on Foundry4

4 Feb 2021 07:00

RNS Number : 9322N
Panoply Holdings PLC (The)
04 February 2021
 

4 February 2021

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Contract wins and update on Foundry4

The Panoply Holdings PLC (AIM: TPX), the technology-enabled services group focused on digital transformation, announces it has recently won two separate contracts in partnership with Mastek, a global IT player, worth more than £7m over the life of the contracts (the "Contracts").

 

Contract wins

 

The Contracts, which run for two years and have been awarded by the NHS Business Services Authority, comprise a £6m framework agreement to provide capabilities to support the organisation's digital transformation agenda and a £1.2m contract to be its overseas digital health delivery partner.

 

Update on Foundry4

 

The Group is pleased to announce that Difrent will be integrated into Foundry4 with effect from 1 April 2021 at which time Rachel Murphy, current CEO of Difrent, will become CEO of Foundry4. Rachel brings a wealth of delivery experience from across the public sector and the healthcare market, providing the foundations for further expansion into this target market for the Group.

 

James Herbert, the current CEO of Foundry4, will take on the role of Strategic Partnerships Director, responsible for the Group's relationships with Microsoft, Amazon (AWS) and Google (GCP). Foundry4's relationships with these key technology platforms are critical to its success. Foundry4 recently attained a Microsoft Gold Cloud Platform competency, demonstrating a "best-in-class" ability and commitment to meet Microsoft Corp. customers' evolving needs in today's mobile-first, cloud-first world as well as distinguishing itself within Microsoft's partner ecosystem. Becoming a Microsoft Gold Partner will allow Foundry4 to combine strengths with Microsoft, speeding up deployment and improvement of Microsoft Azure environments.

 

Neal Gandhi, CEO of The Panoply, said:

 

"These contract wins represent a step-change in our reach into healthcare, a key growth sector for the Group. We look forward to working with Mastek to support the NHS BSA with its ongoing digital transformation agenda.

 

We are also delighted that Difrent, the company whose approach has so impressed to secure these wins, will be joining our Foundry4 brand and that Rachel Murphy will be leading it forward as CEO. With her extensive experience driving digital change, Foundry4 is well placed to strengthen its reputation as a leading provider in digital transformation across the public and private sectors."

 

Rachel Murphy, CEO designate of Foundry4 said:

 

"Even from Difrent's relatively short time as part of the Group, the substantial opportunities available through collaboration and combination among the different businesses is clear.

 

In my role as CEO of Foundry4, I am excited to leverage the varied skills and technical expertise we have in our possession to expand the Group's reach across the markets in which we operate".

 

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

 

 

+44 (0)203 903 7715

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44 (0)203 405 0205

 

 

 

 

About The Panoply

 

The Panoply is a technology-enabled services group, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.70% of its client base representing the public sector and c.30% representing the commercial sector.

More information is available at www.thepanoply.com

 

About Foundry4

 

Foundry4 helps organisations in highly regulated sectors harness technology to solve complex challenges. Its deep technical expertise covers all areas of the digital spectrum, from intelligent automation and user centred design, to high quality product engineering teams and agile coaching.

 

Partnering with enterprise organisations, Foundry4 draw on extensive technology and sector knowledge to help them harness the true value of cloud and data.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBIGDDXDGDGBX
Date   Source Headline
13th May 20249:45 amRNSShare Incentive Plan & Total Voting Rights
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m
14th Sep 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th Sep 20231:05 pmRNSUpdate on Current Trading and Notice of AGM
25th Aug 20231:03 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.